Logos Global Management LP Apellis Pharmaceuticals, Inc. Transaction History

Logos Global Management LP

$1.07 Billion
Q1 2024

A detailed history of Logos Global Management LP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 800,000 shares of APLS stock, worth $30.7 Million. This represents 4.38% of its overall portfolio holdings.

Number of Shares

800,000

Previous 950,000 15.79%

Holding current value

$30.7 Million

Previous $56.9 Million 17.31%

% of portfolio

4.38%

Previous 6.06%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$55.39 - $72.47 $8.31 Million - $10.9 Million	-150,000 Reduced 15.79%	800,000 $47 Million
Q4 2023 Feb 14, 2024	BUY	$37.14 - $64.82 $7.43 Million - $13 Million	200,000 Added 26.67%	950,000 $56.9 Million
Q3 2023 Nov 14, 2023	BUY	$23.65 - $89.22 $2.96 Million - $11.2 Million	125,000 Added 20.0%	750,000 $28.5 Million
Q2 2023 Aug 14, 2023	SELL	$76.68 - $93.31 $13.4 Million - $16.3 Million	-175,000 Reduced 21.88%	625,000 $56.9 Million
Q1 2023 May 15, 2023	SELL	$46.59 - $66.96 $25.6 Million - $36.8 Million	-550,000 Reduced 40.74%	800,000 $52.8 Million

Q4 2022 Feb 14, 2023	BUY	$43.24 - $61.04 $2.16 Million - $3.05 Million	50,000 Added 3.85%	1,350,000 $69.8 Million
Q3 2022 Nov 14, 2022	SELL	$44.76 - $69.66 $8.95 Million - $13.9 Million	-200,000 Reduced 13.33%	1,300,000 $88.8 Million
Q2 2022 Aug 15, 2022	BUY	$35.07 - $59.21 $21 Million - $35.5 Million	600,000 Added 66.67%	1,500,000 $67.8 Million
Q1 2022 May 16, 2022	SELL	$35.46 - $54.12 $3.55 Million - $5.41 Million	-100,000 Reduced 10.0%	900,000 $45.7 Million
Q4 2021 Feb 14, 2022	SELL	$30.74 - $49.16 $13.8 Million - $22.1 Million	-450,000 Reduced 31.03%	1,000,000 $47.3 Million
Q3 2021 Nov 15, 2021	BUY	$31.4 - $69.84 $34.5 Million - $76.8 Million	1,100,000 Added 314.29%	1,450,000 $47.8 Million
Q2 2021 Aug 16, 2021	BUY	$40.9 - $64.9 $14.3 Million - $22.7 Million	350,000 New	350,000 $22.1 Million
Q1 2021 May 17, 2021	SELL	$40.8 - $57.39 $12.2 Million - $17.2 Million	-300,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$30.79 - $57.2 $9.24 Million - $17.2 Million	300,000 New	300,000 $17.2 Million
Q1 2020 May 15, 2020	SELL	$17.91 - $44.33 $10.5 Million - $26 Million	-587,108 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$22.1 - $30.8 $13 Million - $18.1 Million	587,108 New	587,108 $18 Million

Others Institutions Holding APLS

# of Institutions

337

Shares Held

111M

Call Options Held

1.26M

Put Options Held

1.14M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $4.21B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Account

Logos Global Management LP Apellis Pharmaceuticals, Inc. Transaction History